No Data
No Data
American Views on Marijuana Effects Worsening: Gallup
Top Seller Of Pharmaceutical Cannabis Outside US Grew By Double-Digits, Focuses On Germany
Cannabis Stocks Drop as DEA Sets Drug-rescheduling Hearing After November Election
The hearing on the reclassification of cannabis is approaching, and both US cannabis stocks and ETFs are under pressure.
The upcoming open hearing on December 2nd by the US Drug Enforcement Administration has attracted widespread attention from the market, and aims to discuss the proposal to reclassify marijuana.
DEA Sets Hearing on Cannabis Rescheduling and Delays Decision Until After the Election
Cannabis Sales In Canada Decline Sharply: What's Behind The Drop?